Gene · 9656
Papers2,704
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
721 to 740 of 2,704
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| COMMD4 functions with the histone H2A-H2B dimer for the timely repair of DNA double-strand breaks. | Commun Biol | 2021 | 33875784 | PubTator, text mining | PubMed |
| Exploring the Roles of HERC2 and the NEDD4L HECT E3 Ubiquitin Ligase Subfamily in p53 Signaling and the DNA Damage Response. | Front Oncol | 2021 | 33869064 | PubTator, text mining | PubMed |
| In silico Identification of 10 Hub Genes and an miRNA-mRNA Regulatory Network in Acute Kawasaki Disease. | Front Genet | 2021 | 33868359 | PubTator, text mining | PubMed |
| An integrated multi-omics analysis identifies prognostic molecular subtypes of non-muscle-invasive bladder cancer. | Nat Commun | 2021 | 33863885 | PubTator, text mining | PubMed |
| Recruitment of KMT2C/MLL3 to DNA Damage Sites Mediates DNA Damage Responses and Regulates PARP Inhibitor Sensitivity in Cancer. | Cancer Res | 2021 | 33853832 | PubTator, text mining | PubMed |
| Telomeric Double Strand Breaks in G1 Human Cells Facilitate Formation of 5' C-Rich Overhangs and Recruitment of TERRA. | Front Genet | 2021 | 33841503 | PubTator, text mining | PubMed |
| The Molecular Basis of Ubiquitin-Conjugating Enzymes (E2s) as a Potential Target for Cancer Therapy. | Int J Mol Sci | 2021 | 33810518 | PubTator, text mining | PubMed |
| Gastric Cancer: Advances in Carcinogenesis Research and New Therapeutic Strategies. | Int J Mol Sci | 2021 | 33810350 | PubTator, text mining | PubMed |
| Kaempferol and Its Glycoside Derivatives as Modulators of Etoposide Activity in HL-60 Cells. | Int J Mol Sci | 2021 | 33805363 | PubTator, text mining | PubMed |
| Global Proteomics to Study Silica Nanoparticle-Induced Cytotoxicity and Its Mechanisms in HepG2 Cells. | Biomolecules | 2021 | 33801561 | PubTator, text mining | PubMed |
| Immune changes beyond Th2 pathways during rapid multifood immunotherapy enabled with omalizumab. | Allergy | 2021 | 33782956 | PubTator, text mining | PubMed |
| Analyses of peripheral blood dendritic cells and magnetic resonance spectroscopy support dysfunctional neuro-immune crosstalk in Tourette syndrome. | Eur J Neurol | 2021 | 33768607 | PubTator, text mining | PubMed |
| 19-(Benzyloxy)-19-oxojolkinolide B (19-BJB), an ent-abietane diterpene diepoxide, inhibits the growth of bladder cancer T24 cells through DNA damage. | PLoS One | 2021 | 33724994 | PubTator, text mining | PubMed |
| Anti-ceramide single-chain variable fragment mitigates radiation GI syndrome mortality independent of DNA repair. | JCI Insight | 2021 | 33724956 | PubTator, text mining | PubMed |
| Human RecQ Helicases in DNA Double-Strand Break Repair. | Front Cell Dev Biol | 2021 | 33718381 | PubTator, text mining | PubMed |
| Clinical Characteristics of Paediatric Hyperinflammatory Syndrome in the Era of Corona Virus Disease 2019 (COVID-19). | Indian J Clin Biochem | 2021 | 33716413 | PubTator, text mining | PubMed |
| ATM and ATR Activation Through Crosstalk Between DNA Damage Response Pathways. | Bull Math Biol | 2021 | 33704589 | PubTator, text mining | PubMed |
| DOCK7 protects against replication stress by promoting RPA stability on chromatin. | Nucleic Acids Res | 2021 | 33704464 | PubTator, text mining | PubMed |
| FUS-dependent liquid-liquid phase separation is important for DNA repair initiation. | J Cell Biol | 2021 | 33704371 | PubTator, text mining | PubMed |
| RNF8 ubiquitinates RecQL4 and promotes its dissociation from DNA double strand breaks. | Oncogenesis | 2021 | 33674555 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9656/papers?page=37